MedTrace Logo

Genetic of Chronic Kidney Disease and Gout in New Caledonia

NCT05607797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1858

Last updated 2024-11-27

No results posted yet for this study

Summary

The goal of this research is to study the associations of genetic variants of gout and kidney failure, which are very common in the Melanesian population in New Caledonia

Conditions

  • Gout
  • Renal Insufficiency, Chronic

Interventions

OTHER

Epidemiological study

Sociodemographic data collection, treatments collection, physical assessment, clinical examination and physical and biological measurements, biological evaluation (blood and urine samples), CKD-specific clinical features collection, gout-specific clinical features collection, clinical characteristics specific to chronic diseases, questionnaires (Health Assessment Questionnaire (HAQ-II), EuroQol (EQ)-5D-5L, joint pain, state of health, diet and physical activity, access to care, addictions, pain scale (EVA), personal and family history)

Sponsors & Collaborators

  • Variant Bio, Inc.

    collaborator UNKNOWN

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Thomas BARDIN · Hôpital Lariboisière

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • New Caledonia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607797 on ClinicalTrials.gov